An Activatable Prodrug for the Treatment of Metastatic Tumors
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Eun-Joong | - |
dc.contributor.author | Bhuniya, Sankarprasad | - |
dc.contributor.author | Lee, Hyunseung | - |
dc.contributor.author | Kim, Hyun Min | - |
dc.contributor.author | Cheong, Chaejoon | - |
dc.contributor.author | Maiti, Sukhendu | - |
dc.contributor.author | Hong, Kwan Soo | - |
dc.contributor.author | Kim, Jong Seung | - |
dc.date.accessioned | 2021-09-05T04:18:44Z | - |
dc.date.available | 2021-09-05T04:18:44Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2014-10-01 | - |
dc.identifier.issn | 0002-7863 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/97129 | - |
dc.description.abstract | Metastatic cancers have historically been difficult to treat. However, metastatic tumors have been found to have high levels of reactive oxygen species such as hydrogen peroxide (H2O2), supporting the hypothesis that a prodrug could be activated by intracellular H2O2 and lead to a potential antimetastatic therapy. In this study, prodrug 7 was designed to be activated by H2O2-mediated boronate oxidation, resulting in activation of the fluorophore for detection and release of the therapeutic agent, SN-38. Drug release from prodrug 7 was investigated by monitoring fluorescence after addition of H2O2 to the cancer cells. Prodrug 7 activated by H2O2 selectively inhibited tumor cell growth. Furthermore, intratracheally administered produrg 7 showed effective antitumor activity in a mouse model of metastatic lung disease. Thus, this H2O2-responsive prodrug has therapeutic potential as a novel treatment for metastatic cancer via cellular imaging with fluorescence as well as selective release of the anticancer drug, SN-38. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | AMER CHEMICAL SOC | - |
dc.subject | HYDROGEN-PEROXIDE | - |
dc.subject | CANCER-CELLS | - |
dc.subject | BIOMEDICAL APPLICATIONS | - |
dc.subject | OXIDATIVE STRESS | - |
dc.subject | DRUG-DELIVERY | - |
dc.subject | THERAPY | - |
dc.subject | LUNG | - |
dc.subject | NANOPARTICLES | - |
dc.subject | REPORTER | - |
dc.subject | PROGRESS | - |
dc.title | An Activatable Prodrug for the Treatment of Metastatic Tumors | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Jong Seung | - |
dc.identifier.doi | 10.1021/ja5077684 | - |
dc.identifier.scopusid | 2-s2.0-84907483939 | - |
dc.identifier.wosid | 000342608800067 | - |
dc.identifier.bibliographicCitation | JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, v.136, no.39, pp.13888 - 13894 | - |
dc.relation.isPartOf | JOURNAL OF THE AMERICAN CHEMICAL SOCIETY | - |
dc.citation.title | JOURNAL OF THE AMERICAN CHEMICAL SOCIETY | - |
dc.citation.volume | 136 | - |
dc.citation.number | 39 | - |
dc.citation.startPage | 13888 | - |
dc.citation.endPage | 13894 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.subject.keywordPlus | HYDROGEN-PEROXIDE | - |
dc.subject.keywordPlus | CANCER-CELLS | - |
dc.subject.keywordPlus | BIOMEDICAL APPLICATIONS | - |
dc.subject.keywordPlus | OXIDATIVE STRESS | - |
dc.subject.keywordPlus | DRUG-DELIVERY | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | LUNG | - |
dc.subject.keywordPlus | NANOPARTICLES | - |
dc.subject.keywordPlus | REPORTER | - |
dc.subject.keywordPlus | PROGRESS | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.